Green Chemicals Blog
Earnings
Cereplast files for Bankruptcy
It looks like the renewable chemicals/bio-materials industry is now seeing the start of restructuring with LS9 recently being acquired by Renewable Energy Group, Codexis changing its business strategy and focus, and now Cereplast filing for bankruptcy. The Indiana-based bioplastic producer has filed voluntary petition for relief under Chapter 11 in the US Bankruptcy Court led … Continue reading
More ethanol news woes
More bad financial news on the ethanol front after Bluefire Renewables loses DOE grant. KIOR halts production of cellulosic gasoline, diesel and fuel oil at its plant in Columbus, Mississippi to optimize yield, throughput and operability, and to minimize cost. TMO Renewables has ran out of money and has appointed an insolvency administrator to examine … Continue reading
Gevo hoping for a better 2014
The clock is ticking for bio-isobutanol producer Gevo, and it needs to prove as soon as possible that its 18m gal/year Luverne, Minnesota, facility can successfully fully operate. The company needed an influx of cash very quickly and has announced this week a public offering of 18.53 million common shares at $1.35 each. The stock … Continue reading
Codexis exits fatty alcohols project
The big news last month on Codexis’s third quarter earnings call is that the company stopped further development of its CodeXol® detergent alcohols franchise earlier in the year as the company also decided to exit its CodeXyme® cellulase enzymes business. The cellulase enzymes catalyse the conversion of cellulose into fermentable glucose, and it is used to produce … Continue reading
Cereplast’s bioplastic orders coming in
Bioplastic producer Cereplast received five purchase orders totaling $450,000 from an existing customer in India for Cereplast Compostables® blown film resins. Each purchase order totals $90,000 and will be delivered throughout the remainder of 2013. The bioplastic resins will be used for the manufacturing of single-use disposable bags for distribution in the Sri Lankan and … Continue reading
BioAmber phases out E.coli use
The blog is just catching up with some of the earnings conference calls from last week. Here are some highlighted information from BioAmber. I am also checking out Codexis, Cereplast and Syntroleum if they have any interesting updates for the quarter. An interesting information from BioAmber’s recent earnings call is the phasing out its use of E.coli … Continue reading
Amyris lowers farnesene costs
This will be my last post for the week before I venture off to my week-long vacation (Woohoo!). The blog gets some update late Thursday from Amyris’ second quarter earnings report and conference call. One of the major highlight of the company’s results is that the company reportedly hopes to achieve its cost target for … Continue reading
Solazyme partners with Sasol on erucic algal oils
The oleochemical industry is definitely getting more and more interesting as erucic acid (C22:1), traditionally sourced from high erucic rapeseed oils (HERO), can now be sourced from algal oils as is the case with Solazyme’s recent announcement. I remember the old days when I used to cover this niche market for Chemical Market Reporter. The … Continue reading
Gevo updates bio-isobutanol production plans
Earnings season is in full force for the next week or so, and unfortunately (or maybe fortunately??) I will be on vacation with no internet connection starting this Sunday. By the way, it was a pleasure talking with OPX Biotechnology CEO Charles Eggert again as he gave the blog updates on the company’s activities and … Continue reading
Codexis battles with Dyadic on enzymes
Codexis has received notice from Dyadic International alleging that Codexis is in breach under a license agreement established by the companies on November 14, 2008. According to the notice, Dyadic intends to terminate the agreement in 60 days if the breach is not cured to Dyadic’s satisfaction. Codexis said it is considering all available remedies … Continue reading